NCT02735798 2017-05-04
64-Cu Labeled Brain PET/MRI for MM-302 in Advanced HER2+ Cancers With Brain Mets
University of California, San Francisco
Phase EARLY_PHASE1 Withdrawn
University of California, San Francisco
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals